Fig. 7From: Peptidase inhibitor (PI16) impairs bladder cancer metastasis by inhibiting NF-κB activation via disrupting multiple-site ubiquitination of NEMOProposed model diagram of PI16 inhibition of NF-κB signalling pathway and BLCA metastasisBack to article page